Egberts A C, Meyboom R H, De Koning F H, Bakker A, Leufkens H G
Netherlands Pharmacovigilance Foundation LAREB, Tilburg, The Netherlands.
Br J Clin Pharmacol. 1997 Sep;44(3):277-81. doi: 10.1046/j.1365-2125.1997.00652.x.
The aim of the present study was to estimate the relative risk of non-puerperal lactation in patients using antidepressants in general, and specifically for serotonergic (selective serotonin reuptake inhibitors (SSRIs) and clomipramine) and non-serotonergic antidepressants.
All suspected adverse drug reactions in women and reported from January 1986 until August 1996 to the Netherlands Pharmacovigilance Foundation, a spontaneous adverse drug reaction reporting programme, were analysed. Adverse drug reaction (ADR) reporting odds ratios, defined as the ratio of the exposure odds among reported cases of non-puerperal lactation to the exposure odds of reported other ADRs, were calculated adjusted for age and year of reporting.
Thirty-eight cases of non-puerperal lactation were reported, of which 15 were associated with the use of antidepressant drugs. In general, antidepressants were associated with a higher risk of non-puerperal lactation in comparison with other drugs (ADR reporting odds ratio 8.3 [95%CI: 4.3-16.1]). Serotonergic antidepressants (selective serotonin reuptake inhibitors (SSRIs) and clomipramine) were associated with a higher risk (OR 12.7 [95%CI: 6.4-25.4]), whereas other antidepressants were not (OR 1.6 [95%CI: 0.2-11.6]), compared with all other drugs.
Our results indicate that serotonergic antidepressants are associated with an approximately eight times higher risk of non-puerperal lactation compared with other antidepressants. This effect is probably mediated by an indirect inhibition effect of serotonin on the dopaminergic transmission. This finding is in line with the occurrence of other antidopaminergic effects, such as extrapyramidal symptoms, in patients using serotonergic antidepressants.
本研究旨在评估一般使用抗抑郁药的患者发生非产褥期泌乳的相对风险,特别是血清素能(选择性5-羟色胺再摄取抑制剂(SSRI)和氯米帕明)和非血清素能抗抑郁药的情况。
分析了1986年1月至1996年8月期间向荷兰药物警戒基金会报告的所有女性疑似药物不良反应,该基金会是一个自发的药物不良反应报告项目。计算药物不良反应(ADR)报告比值比,定义为非产褥期泌乳报告病例中的暴露比值与其他ADR报告的暴露比值之比,并根据年龄和报告年份进行调整。
报告了38例非产褥期泌乳病例,其中15例与使用抗抑郁药有关。总体而言,与其他药物相比,抗抑郁药与非产褥期泌乳的风险更高相关(ADR报告比值比8.3 [95%置信区间:4.3 - 16.1])。与所有其他药物相比,血清素能抗抑郁药(选择性5-羟色胺再摄取抑制剂(SSRI)和氯米帕明)的风险更高(比值比12.7 [95%置信区间:6.4 - 25.4]),而非其他抗抑郁药(比值比1.6 [95%置信区间:0.2 - 11.6])。
我们的结果表明,与其他抗抑郁药相比,血清素能抗抑郁药导致非产褥期泌乳的风险高出约八倍。这种效应可能是由血清素对多巴胺能传递的间接抑制作用介导的。这一发现与使用血清素能抗抑郁药的患者出现其他抗多巴胺能效应(如锥体外系症状)的情况一致。